Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at $575,000.

The Guardian Trust Early Career Fellowship represents a bold commitment to fostering a new generation of leaders in brain cancer research. By providing comprehensive support over a five-year period, Cure Brain Cancer Foundation is empowering young researchers to pursue ideas that challenge the norm and help pioneer breakthroughs that will redefine the fight against brain cancer.

"Innovation in a field such as brain cancer only thrives when you nurture talent and provide opportunities," remarked Lance Kawaguchi, CEO of Cure Brain Cancer Foundation. "Following the successful launch of GBM AGILE in 2023, the Foundation is proud to demonstrate its commitment to pioneering solutions that accelerate progress in the field."

Dr. Hamza Anwer, Head of Research at Cure Brain Cancer Foundation, emphasized the critical importance of attracting talent in a rare cancer field and providing stability to focus on the research. "Brain cancer research requires a relentless pursuit of excellence and innovation. By attracting bright young minds through initiatives like the first ever 5-Year Guardian Trust Early Career Fellowship, we are not only expanding our research capacity but also fostering a supportive environment where researchers can thrive and make meaningful contributions to this challenging field."

Applications for the Guardian Trust Early Career Fellowship open on the 22nd of April 2024.

View Cure Brain Cancer Foundation's website for T&C's and more information: https://www.curebraincancer.org.au/research/for-researchers/funding-opportunities-2024.